[{"Assets_0_Q3_USD":853083000.0,"CommonStockSharesOutstanding_0_Q3_shares":143803000.0,"EarningsPerShareBasic_3_Q3_USD":-0.46,"EarningsPerShareBasic_1_Q3_USD":0.35,"EarningsPerShareDiluted_1_Q3_USD":0.34,"EarningsPerShareDiluted_3_Q3_USD":-0.46,"NetIncomeLoss_3_Q3_USD":-66329000.0,"NetIncomeLoss_1_Q3_USD":50021000.0,"StockholdersEquity_0_Q3_USD":659708000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":142876000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":148068000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":143357000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":142876000.0,"Ticker":"SGEN","CIK":"1060736","name":"SEATTLE GENETICS INC \/WA","OfficialName":"Seagen Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"26523270348.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20171106"}]